IIM
CPHR

Intact Investment Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Intact Investment Management’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-355,500
Closed -$1.78M – 309
2016
Q3 		$1.78M Sell
355,500
-20,000
-5% -$91.1K 0.07% 127
2016
Q2 		$2.44M Sell
375,500
-153,100
-29% -$873K 0.1% 109
2016
Q1 		$3.28M Buy
528,600
+8,300
+2% +$36.4K 0.13% 91
2015
Q4 		$3.25M Sell
520,300
-214,600
-29% -$929K 0.14% 96
2015
Q3 		$3.6M Buy
734,900
+313,400
+74% +$2.18M 0.16% 91
2015
Q2 		$4.36M Buy
421,500
+129,100
+44% +$1.29M 0.18% 90
2015
Q1 		$3.35M Sell
292,400
-77,100
-21% -$968K 0.14% 98
2014
Q4 		$6.19M Buy
+369,500
New +$5.36M 0.25% 75

Other funds holding CPHR

GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Intact Investment Management's CPHR Position: Q4 2016 in Review

Intact Investment Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 355,500 shares — an estimated $1.78M sold.

Intact Investment Management first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $6.19M in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

  • Intact Investment Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
  • Intact Investment Management sold 355,500 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $1.78M.
  • Intact Investment Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
  • Intact Investment Management's Cipher Pharmaceuticals Inc. position peaked at $6.19M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Intact Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.